Obinepitide

From Ganfyd

Jump to: navigation, search

Investigational drug for obesity in phase 2 trials. It combines the Y4 receptor stimulation properties of pancreatic polypeptide form which it is derived with Gln-63 substitution with PYY-2 that acts on the Y2 receptor.

Personal tools